CRISPR Therapeutics AG SEC filings CRSP
CRISPR Therapeutics AG has 880 filings in SEC EDGAR's recent list, going back to May 13, 2016. Its latest annual report, Form ARS, was filed on Apr 21, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 2, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 2, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 3 | Initial insider ownership | Nov 2, 2026 | Nov 2, 2026 |
| 10-Q | Quarterly report | Nov 2, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations
|
Nov 2, 2026 | Nov 2, 2026 |
| 4 | Insider transaction | Oct 28, 2026 | Oct 26, 2026 |
| 4 | Insider transaction | Oct 28, 2026 | Oct 26, 2026 |
| 4 | Insider transaction | Oct 28, 2026 | Oct 26, 2026 |
| 4 | Insider transaction | Oct 28, 2026 | Oct 26, 2026 |
| 4 | Insider transaction | Oct 21, 2026 | Oct 19, 2026 |
| 3 | Initial insider ownership | Oct 21, 2026 | Oct 19, 2026 |
| 4 | Insider transaction | Oct 20, 2026 | Oct 16, 2026 |
| 8-K |
Current report
Officer or director change
|
Oct 19, 2026 | Oct 19, 2026 |
| 4 | Insider transaction | Oct 16, 2026 | Oct 14, 2026 |
| 4 | Insider transaction | Oct 15, 2026 | Oct 13, 2026 |
| 4 | Insider transaction | Oct 15, 2026 | Oct 13, 2026 |
| 144 | Notice of proposed sale | Oct 14, 2026 | — |
| 4 | Insider transaction | Oct 8, 2026 | Oct 6, 2026 |
| 144 | Notice of proposed sale | Oct 6, 2026 | — |
| 4 | Insider transaction | Sep 24, 2026 | Sep 22, 2026 |
| 144 | Notice of proposed sale | Sep 22, 2026 | — |
| 4 | Insider transaction | Sep 21, 2026 | Sep 17, 2026 |
| 4 | Insider transaction | Sep 21, 2026 | Aug 6, 2025 |
| 144 | Notice of proposed sale | Sep 17, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2026 | — |
| 4 | Insider transaction | Aug 11, 2026 | Aug 7, 2026 |
| 10-Q | Quarterly report | Aug 3, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 3, 2026 | Aug 3, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jul 27, 2026 | — |
| 4 | Insider transaction | Jun 9, 2026 | Jun 5, 2026 |
| 4 | Insider transaction | Jun 9, 2026 | Jun 5, 2026 |
| 4 | Insider transaction | Jun 9, 2026 | Jun 5, 2026 |
| 4 | Insider transaction | Jun 9, 2026 | Jun 5, 2026 |
| 4 | Insider transaction | Jun 9, 2026 | Jun 5, 2026 |
| 4 | Insider transaction | Jun 9, 2026 | Jun 5, 2026 |
| 4 | Insider transaction | Jun 9, 2026 | Jun 5, 2026 |
| 4 | Insider transaction | Jun 9, 2026 | Jun 5, 2026 |
| 4 | Insider transaction | Jun 9, 2026 | Jun 5, 2026 |
| 4 | Insider transaction | Jun 9, 2026 | Jun 5, 2026 |
| S-8 | Employee stock plan registration | Jun 5, 2026 | — |
| 8-K |
Current report
Officer or director change, Bylaw or fiscal year change, Shareholder vote results
|
Jun 4, 2026 | Jun 4, 2026 |
| 4 | Insider transaction | Jun 2, 2026 | May 29, 2026 |
| 4 | Insider transaction | Jun 2, 2026 | May 29, 2026 |
| 4 | Insider transaction | Jun 2, 2026 | May 29, 2026 |
| 4 | Insider transaction | Jun 1, 2026 | May 28, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | May 14, 2026 | — |
| 10-Q | Quarterly report | May 4, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
May 4, 2026 | May 4, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Apr 30, 2026 | — |
| ARS | Annual report to shareholders | Apr 21, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Apr 21, 2026 | — |
| DEF 14A | Proxy statement | Apr 21, 2026 | Jun 4, 2026 |
| PRE 14A | Preliminary proxy statement | Apr 2, 2026 | Jun 4, 2026 |
| 4 | Insider transaction | Mar 24, 2026 | Mar 20, 2026 |
| 4 | Insider transaction | Mar 24, 2026 | Mar 20, 2026 |
| 4 | Insider transaction | Mar 24, 2026 | Mar 20, 2026 |
| 4 | Insider transaction | Mar 24, 2026 | Mar 20, 2026 |
| 4 | Insider transaction | Mar 17, 2026 | Mar 14, 2026 |
| 4 | Insider transaction | Mar 17, 2026 | Mar 14, 2026 |
| 4 | Insider transaction | Mar 17, 2026 | Mar 14, 2026 |
| 4 | Insider transaction | Mar 17, 2026 | Mar 14, 2026 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Mar 16, 2026 | Mar 16, 2026 |
| 4 | Insider transaction | Mar 12, 2026 | Mar 10, 2026 |
| 4 | Insider transaction | Mar 12, 2026 | Mar 10, 2026 |
| 8-K |
Current report
Other events
|
Mar 11, 2026 | Mar 10, 2026 |
| 4 | Insider transaction | Feb 20, 2026 | Feb 18, 2026 |
| 4 | Insider transaction | Feb 20, 2026 | Feb 18, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 17, 2026 | — |
| 10-K | Annual report | Feb 12, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Feb 12, 2026 | Feb 12, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 5, 2026 | — |
| 4 | Insider transaction | Jan 27, 2026 | Apr 3, 2025 |
| 4 | Insider transaction | Jan 26, 2026 | Jan 22, 2026 |
| 4 | Insider transaction | Jan 22, 2026 | Jan 20, 2026 |
| 144 | Notice of proposed sale | Jan 22, 2026 | — |
| 144 | Notice of proposed sale | Jan 22, 2026 | — |
| 144 | Notice of proposed sale | Jan 20, 2026 | — |
| 8-K |
Current report
Other events
|
Jan 12, 2026 | Jan 12, 2026 |
| 4 | Insider transaction | Jan 8, 2026 | Jan 6, 2026 |
| 144 | Notice of proposed sale | Jan 6, 2026 | — |
| 4 | Insider transaction | Dec 23, 2025 | Dec 22, 2025 |
| 4 | Insider transaction | Dec 22, 2025 | Dec 18, 2025 |
| 144 | Notice of proposed sale | Dec 22, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Nov 14, 2025 | — |
| 10-Q | Quarterly report | Nov 10, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 10, 2025 | Nov 10, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 4, 2025 | — |
| 4 | Insider transaction | Oct 20, 2025 | Oct 16, 2025 |
| 4 | Insider transaction | Oct 15, 2025 | Oct 13, 2025 |
| 4 | Insider transaction | Oct 15, 2025 | Oct 13, 2025 |
| 8-K |
Current report
Other events
|
Oct 15, 2025 | Oct 15, 2025 |
| 424B5 | Prospectus supplement | Oct 15, 2025 | — |
| 4 | Insider transaction | Oct 3, 2025 | Oct 3, 2025 |
| 4 | Insider transaction | Oct 3, 2025 | Oct 3, 2025 |
| 4 | Insider transaction | Oct 3, 2025 | Oct 3, 2025 |
| 4 | Insider transaction | Oct 3, 2025 | Oct 3, 2025 |
| 4 | Insider transaction | Sep 19, 2025 | Sep 17, 2025 |
| 4 | Insider transaction | Aug 19, 2025 | Aug 16, 2025 |
| 4 | Insider transaction | Aug 8, 2025 | Aug 6, 2025 |
| 10-Q | Quarterly report | Aug 4, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 4, 2025 | Aug 4, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Jul 17, 2025 | — |
| 4 | Insider transaction | Jul 17, 2025 | Jul 16, 2025 |
| 8-K |
Current report
Other events
|
Jun 26, 2025 | Jun 26, 2025 |
| 3/A | Filing | Jun 10, 2025 | Jun 5, 2025 |
| 8-K |
Current report
Bylaw or fiscal year change, Shareholder vote results
|
Jun 9, 2025 | Jun 5, 2025 |
| 4 | Insider transaction | Jun 6, 2025 | Jun 5, 2025 |
| 4 | Insider transaction | Jun 6, 2025 | Jun 5, 2025 |
| 4 | Insider transaction | Jun 6, 2025 | Jun 5, 2025 |
| 4 | Insider transaction | Jun 6, 2025 | Jun 5, 2025 |
| 4 | Insider transaction | Jun 6, 2025 | Jun 5, 2025 |
| 4 | Insider transaction | Jun 6, 2025 | Jun 5, 2025 |
| 4 | Insider transaction | Jun 6, 2025 | Jun 5, 2025 |
| 4 | Insider transaction | Jun 6, 2025 | Jun 5, 2025 |
| 4 | Insider transaction | Jun 6, 2025 | Jun 5, 2025 |
| 4 | Insider transaction | Jun 6, 2025 | Jun 5, 2025 |
| 3 | Initial insider ownership | Jun 6, 2025 | Jun 5, 2025 |
| 4 | Insider transaction | Jun 3, 2025 | May 30, 2025 |
| 4 | Insider transaction | Jun 3, 2025 | May 30, 2025 |
| 4 | Insider transaction | May 30, 2025 | May 28, 2025 |
| 424B5 | Prospectus supplement | May 19, 2025 | — |
| 8-K |
Current report
Material agreement, Other events
|
May 19, 2025 | May 19, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 13, 2025 | — |
| 10-Q | Quarterly report | May 6, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
May 6, 2025 | May 6, 2025 |
| ARS | Annual report to shareholders | Apr 16, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Apr 16, 2025 | — |
| DEF 14A | Proxy statement | Apr 16, 2025 | Jun 5, 2025 |
| PRE 14A | Preliminary proxy statement | Apr 3, 2025 | Jun 5, 2025 |
| 8-K |
Current report
Officer or director change
|
Mar 26, 2025 | Mar 24, 2025 |
| 4 | Insider transaction | Mar 24, 2025 | Mar 20, 2025 |
| 4 | Insider transaction | Mar 24, 2025 | Mar 20, 2025 |
| 4 | Insider transaction | Mar 24, 2025 | Mar 20, 2025 |
| 4 | Insider transaction | Mar 24, 2025 | Mar 20, 2025 |
| 4 | Insider transaction | Mar 18, 2025 | Mar 14, 2025 |
| 4 | Insider transaction | Mar 18, 2025 | Mar 14, 2025 |
| 4 | Insider transaction | Mar 18, 2025 | Mar 14, 2025 |
| 4 | Insider transaction | Mar 18, 2025 | Mar 14, 2025 |
| 4 | Insider transaction | Mar 18, 2025 | Mar 14, 2025 |
| 4 | Insider transaction | Mar 12, 2025 | Mar 10, 2025 |
| 4 | Insider transaction | Mar 12, 2025 | Mar 10, 2025 |
| 4 | Insider transaction | Mar 12, 2025 | Mar 10, 2025 |
| 4 | Insider transaction | Feb 28, 2025 | Feb 26, 2025 |
| 4 | Insider transaction | Feb 21, 2025 | Feb 19, 2025 |
| 4 | Insider transaction | Feb 19, 2025 | Feb 18, 2025 |
| 4 | Insider transaction | Feb 19, 2025 | Feb 18, 2025 |
| 4 | Insider transaction | Feb 19, 2025 | Feb 16, 2025 |
| 144 | Notice of proposed sale | Feb 18, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 14, 2025 | — |
| 10-K | Annual report | Feb 11, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations
|
Feb 11, 2025 | Feb 11, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jan 10, 2025 | — |
| 4 | Insider transaction | Dec 27, 2024 | Dec 24, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Dec 10, 2024 | — |
| 4 | Insider transaction | Dec 4, 2024 | Dec 2, 2024 |
| 4 | Insider transaction | Nov 13, 2024 | Nov 11, 2024 |
| 144 | Notice of proposed sale | Nov 12, 2024 | — |
| 10-Q | Quarterly report | Nov 5, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 5, 2024 | Nov 5, 2024 |
| 4 | Insider transaction | Oct 18, 2024 | Oct 16, 2024 |
| 4 | Insider transaction | Oct 18, 2024 | Oct 16, 2024 |
| 4 | Insider transaction | Oct 18, 2024 | Oct 16, 2024 |
| 4 | Insider transaction | Oct 18, 2024 | Oct 16, 2024 |
| 4 | Insider transaction | Oct 18, 2024 | Oct 16, 2024 |
| 4 | Insider transaction | Oct 15, 2024 | Oct 13, 2024 |
| 4 | Insider transaction | Oct 15, 2024 | Oct 13, 2024 |
| 4 | Insider transaction | Aug 12, 2024 | Aug 8, 2024 |
| S-3ASR | Automatic shelf registration | Aug 5, 2024 | — |
| S-8 | Employee stock plan registration | Aug 5, 2024 | — |
| 10-Q | Quarterly report | Aug 5, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 5, 2024 | Aug 5, 2024 |
| 4 | Insider transaction | Jun 24, 2024 | Jun 20, 2024 |
| 8-K |
Current report
Officer or director change, Bylaw or fiscal year change, Shareholder vote results
|
Jun 3, 2024 | May 30, 2024 |
| 4 | Insider transaction | May 31, 2024 | May 30, 2024 |
| 4 | Insider transaction | May 31, 2024 | May 30, 2024 |
| 4 | Insider transaction | May 31, 2024 | May 30, 2024 |
| 4 | Insider transaction | May 31, 2024 | May 30, 2024 |
| 4 | Insider transaction | May 31, 2024 | May 30, 2024 |
| 4 | Insider transaction | May 31, 2024 | May 30, 2024 |
| 4 | Insider transaction | May 31, 2024 | May 30, 2024 |
| 4 | Insider transaction | May 31, 2024 | May 30, 2024 |
| 4 | Insider transaction | May 31, 2024 | May 30, 2024 |
| 3 | Initial insider ownership | May 30, 2024 | May 30, 2024 |
| 3 | Initial insider ownership | May 30, 2024 | May 30, 2024 |
| 4 | Insider transaction | May 29, 2024 | May 28, 2024 |
| 3 | Initial insider ownership | May 28, 2024 | May 28, 2024 |
| 4 | Insider transaction | May 24, 2024 | May 23, 2024 |
| 3 | Initial insider ownership | May 23, 2024 | May 23, 2024 |
| 8-K |
Current report
Officer or director change
|
May 23, 2024 | May 23, 2024 |
| 10-Q | Quarterly report | May 8, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations
|
May 8, 2024 | May 8, 2024 |
| 4 | Insider transaction | Apr 17, 2024 | Apr 15, 2024 |
| 144 | Notice of proposed sale | Apr 15, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Apr 10, 2024 | — |
| ARS | Annual report to shareholders | Apr 9, 2024 | Dec 31, 2023 |
| DEFA14A | Additional proxy material | Apr 9, 2024 | — |
| DEF 14A | Proxy statement | Apr 9, 2024 | May 30, 2024 |
| PRE 14A | Preliminary proxy statement | Mar 27, 2024 | May 30, 2024 |
| 4 | Insider transaction | Mar 22, 2024 | Mar 20, 2024 |
| 4 | Insider transaction | Mar 22, 2024 | Mar 20, 2024 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- CRSP (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Switzerland
- Headquarters
- Zug
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1674416
- Former names
- CRISPR Therapeutics AG (until Nov 2, 2026)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.